Description:
A drug used to treat adults with cutaneous squamous cell carcinoma (a type of skin cancer) that has spread and cannot be cured with surgery or radiation therapy. It is also being studied in the treatment of other types of cancer. Unloxcyt binds to a protein called PD-L1, which is found on some normal cells and some types of cancer cells. Blocking this protein may help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called cosibelimab.
